WORKFORCE READINESS TECHNOLOGY MINIMIZES RISK IN CLINICAL TRIALS.
- Published in:
- 2019
- Publication type:
- Interview
Works matching IS 10648542 AND DT 2019 AND VI 28 AND IP 9
Results: 13
1
2
NO END IN SIGHT TO EUROPEAN DEBATES ABOUT DRUG FIRMS' INFLUENCE ON REGULATORS.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 7
- By:
- Publication type:
- Article
3
How Organizations Can Put Sites First When Implementing New Trial Technology: Organizations that continue to disregard the technological needs of one of the industry's core audiences run the risk of having their trials ignored.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 34
- By:
- Publication type:
- Article
4
Improving Information Exchange in Clinical Trials: Executives from across the clinical research enterprise converge to discuss the steps--and technology--needed to strengthen industrywide data sharing.
- Published in:
- 2019
- By:
- Publication type:
- Interview
5
The Changing Landscape for Clinical Trial Sites: Exploring how clinical research sites are redefining their business models to be more flexible, collaborative, and customized.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 24
- By:
- Publication type:
- Article
6
Creating Medicines 'Appropriate for All': Bristol-Myers Squibb's cardiovascular development leader discusses the importance of diversifying clinical trials for better patient outcomes.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 22
- By:
- Publication type:
- Article
7
Retention Strategies for Keeping Participants Engaged: A case study of the Parkinson's Progression Markers Initiative.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 20
- By:
- Publication type:
- Article
8
The VA Gets Real on Reform: After years of siloed focus--and slow study start-ups--the U.S. Veterans Affairs agency embarks on implementing its multi-year initiative to bolster clinical research.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 18
- By:
- Publication type:
- Article
9
PROLIFERATION OF RARE DISEASE R&D NECESSITATING NOVEL STRATEGIES: Interest in benchmark data on the scope, performance, and economics of these efforts has grown.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 16
- By:
- Publication type:
- Article
10
NEW COLLABORATION TARGETS PANCREATIC CANCER.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 14
- Publication type:
- Article
11
MIXED PATIENT SUPPORT OF DATA-SHARING INITIATIVES.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 14
- By:
- Publication type:
- Article
12
SPONSORS, REGULATORS CAUTIOUS ABOUT RISK-BASED OVERSIGHT OF CLINICAL TRIALS.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 6
- By:
- Publication type:
- Article
13
Taking Care of Site Business.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 9, p. 3
- By:
- Publication type:
- Article